KPIs & Operating Metrics(New)
Advance Purchase Agreements (Apas)Breakdown Of AssetsCollabration Revenue By CategoryCollabration Revenue By Category AnnualCost Of SalesDeferred Revenue By SegmentDoses DeliveredEmployee StatisticsGrant Revenue By Category AnnualGrant Revenue By CategoyGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionManufacturing Technology Center (Mtc)Operating Expense As A % Of Total Revenue %Operating Expense SegregationProduct Revenue By Geography %Product Revenue By Geography Annual %Product Sales By GeographyProduct Sales By Geography AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment BreakdownProperty And Equipment By GeographyPurchase CommitmentsRemaining Performance ObligationRemaining Performance ObligationsRevenue By Major CustomersRevenue By Major Customers %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Contractual Obligations AnnualTotal Deferred Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Gross Profit (2021 - 2025)

Moderna (MRNA) has disclosed Gross Profit for 6 consecutive years, with $226.0 million as the latest value for Q4 2025.

  • Quarterly Gross Profit changed 0.44% to $226.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, down 36.97% year-over-year, with the annual reading at $1.1 billion for FY2025, 39.28% down from the prior year.
  • Gross Profit for Q4 2025 was $226.0 million at Moderna, down from $809.0 million in the prior quarter.
  • The five-year high for Gross Profit was $6.3 billion in Q4 2021, with the low at -$410.0 million in Q3 2023.
  • Average Gross Profit over 5 years is $1.8 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Gross Profit soared 21700.0% in 2021, then crashed 118.11% in 2023.
  • Over 5 years, Gross Profit stood at $6.3 billion in 2021, then decreased by 25.16% to $4.7 billion in 2022, then plummeted by 59.82% to $1.9 billion in 2023, then crashed by 87.94% to $227.0 million in 2024, then decreased by 0.44% to $226.0 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $226.0 million, $809.0 million, and $23.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.